arthritis

Advertisement
Patrick DalyOncology | October 4, 2022
Adverse events related to immune checkpoint inhibitor (ICI) therapy lack alternative treatments outside of ...
Read More
Patrick DalyPsoriasis | April 12, 2023
Psoriatic arthritis (PsA) is an inflammatory disease that commonly affects patients with psoriasis. According to a study ...
Rebecca AraujoPsoriatic Arthritis | April 10, 2023
Ixekizumab demonstrated favorable tolerability and safety, in line with previous reports, for treatment of psoriatic ...
Rob DillardTelemedicine | May 2, 2023
A recent study from CreakyJoints, the digital, international patient community for people with all forms of arthritis, ...
Rob DillardRheumatology | April 27, 2023
Recently, CreakyJoints, the digital, international patient community for people with all forms of arthritis, announced a ...
DocWire News EditorsRheumatology | September 10, 2021
NAMS Updates Position Statement on Osteoporosis Management ...
DocWire News EditorsRheumatology | April 23, 2023
RA Predictors ID'd in Undifferentiated Large Joint Arthritis ...
Rebecca AraujoRheumatoid Arthritis | April 7, 2023
Expectant and recent mothers often choose to forego antirheumatic drugs to treat inflammatory arthritis out of concerns ...
Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023
A study observed a correlation between patients’ expectations toward newly induced disease-modifying antirheumatic ...
Kaitlyn D’OnofrioRheumatology | May 21, 2021
Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to ...
Kaitlyn D’OnofrioRheumatology | May 14, 2021
A recent study observed differences in oral microbiome between patients with early rheumatoid arthritis (RA) or at ...
Kaitlyn D’OnofrioRheumatoid Arthritis | April 28, 2023
Benjamin Nowell, Ph.D, Director of Patient-Centered Research, CreakyJoints, and principal investigator of ...
Kaitlyn D’OnofrioRheumatology | February 25, 2021
The results of a new study suggest that there may be a way to use anakinra in the treatment of severe COVID-19. ...
Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023
A study evaluated the use of biologic disease-modifying antirheumatic drugs (bDMARDs) in the treatment of rheumatoid ...
Kaitlyn D’OnofrioCOVID-19 | April 6, 2023
Glucocorticoids in the treatment of arthritis may increase the risk for COVID-19 infection, while ...
Kaitlyn D’OnofrioACR 2020 Conference | August 1, 2023
A study that was presented as part of the American College of Rheumatology (ACR) Convergence 2020 assessed how a ...
Kaitlyn D’OnofrioRheumatology | April 24, 2023
Vitamin D, Omega-3 Fatty Acid, or Strength Training: Which Is Best for Healthy Older Adults? The Answer, None of the ...
Kaitlyn D’OnofrioCOVID-19 | April 7, 2023
Many people have taken to social media to express their thoughts surrounding the COVID-19 pandemic. Since people with ...
Kaitlyn D’OnofrioRheumatology | October 23, 2020
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read two ...
Kaitlyn D’OnofrioRheumatology | October 22, 2020
Providers may not be engaging with their inflammatory arthritis (IA) patients about the importance of exercise, ...
Advertisement
Advertisement
Advertisement
Latest News

July 12, 2024